Innate Pharma: Clarification Regarding SAR443579 Designation

Regulatory News:


Innate Pharma SA today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by Sanofi, it...

Related Keywords

France ,French , ,European Hematology Association ,Exchange Commission ,Linkedin ,Company Annual Report On Form ,Nasdaq ,French Financial Markets Authority ,Euronext ,Astrazeneca ,Regulatory News ,Euronext Paris ,Track Designation ,Engager Therapeutics ,Innate Pharma ,Private Securities Litigation Reform Act ,Risk Factors ,Universal Registration Document ,Annual Report ,